GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Annexin Pharmaceuticals AB (OSTO:ANNX) » Definitions » Cash Received from Insurance Activities

Annexin Pharmaceuticals AB (OSTO:ANNX) Cash Received from Insurance Activities


View and export this data going back to 2017. Start your Free Trial

What is Annexin Pharmaceuticals AB Cash Received from Insurance Activities?

Cash Received from Insurance Activities only applicable to companies reporting Cash Flow from Operations in direct method.


Annexin Pharmaceuticals AB (OSTO:ANNX) Business Description

Industry
Traded in Other Exchanges
Address
Norrtullsgatan 6, Stockholm, SWE, SE-113 29
Annexin Pharmaceuticals AB is a biotechnology company. It is developing biological drug candidate ANXV, a recombinant human protein Annexin A5 for treatment of various cardiovascular diseases. The company also focuses on development of ANXV for the treatment of retinal vein occlusion.